BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1470136)

  • 21. Endoscopic sclerotherapy of oesophageal varices. A clinical study.
    Söderlund C
    Acta Chir Scand Suppl; 1985; 524():1-86. PubMed ID: 3893006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Elective-selective Warren splenorenal shunt operation. Prognosis of liver function and esophageal varices hemorrhage after repeat sclerotherapy in liver cirrhosis].
    Paquet KJ; Lazar A; Mercado MA; Gad HA
    Chirurg; 1991 Nov; 62(11):794-8; discussion 798-9. PubMed ID: 1769259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
    Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
    Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
    Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
    Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerotherapy with or without octreotide for acute variceal bleeding.
    Besson I; Ingrand P; Person B; Boutroux D; Heresbach D; Bernard P; Hochain P; Larricq J; Gourlaouen A; Ribard D
    N Engl J Med; 1995 Aug; 333(9):555-60. PubMed ID: 7623904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophagogastric devascularization as the last option in the management of variceal bleeding.
    Král V; Klein J; Havlík R; Aujeský R; Utíkal P
    Hepatogastroenterology; 2002; 49(43):244-6. PubMed ID: 11941965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
    Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
    [TBL] [Abstract][Full Text] [Related]  

  • 28.  Schistosomal portal hypertension: Randomized trial comparing endoscopic therapy alone or preceded by esophagogastric devascularization and splenectomy.
    Costa Lacet CM; Neto JB; Ribeiro LT; Oliveira FS; Wyszomirska RF; Strauss E
    Ann Hepatol; 2016; 15(5):738-44. PubMed ID: 27493113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of non-decompression surgery for esophago-gastric varices--postoperative disappearance, recurrence, rebleeding rate of varices, and cumulative survival rate].
    Beppu T; Maruyama T; Ohashi K; Ohura S; Nakanishi R; Fukasawa M; Futagawa S
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1159-63. PubMed ID: 1470135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of endoscopic injection sclerotherapy and esophageal transection].
    Hagiwara M; Sakai M; Nagaoka S; Nakano S; Okano T; Okada T; Katayama K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1153-5. PubMed ID: 1470133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications and limitations of injection sclerotherapy in portal hypertension.
    Heaton ND; Howard ER
    Gut; 1993 Jan; 34(1):7-10. PubMed ID: 8432456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Devascularization and transection procedures.
    Idezuki Y
    HPB Surg; 1991 May; 4(1):33-8; discussion 39-47. PubMed ID: 1911475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of patients with portal hypertension and oesophageal varices.
    Terblanche J
    S Afr Med J; 1980 Apr; 57(16):616-9. PubMed ID: 7376025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of sclerotherapy for the management of oesophageal varices in portal hypertension.
    Terblanche J
    Surg Endosc; 1988; 2(3):149-55. PubMed ID: 3070799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy.
    McCormick PA; Kaye GL; Greenslade L; Cardin F; Hobbs KE; McIntyre N; Burroughs AK
    Hepatology; 1992 Mar; 15(3):403-6. PubMed ID: 1544620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.
    Debray D; Lykavieris P; Gauthier F; Dousset B; Sardet A; Munck A; Laselve H; Bernard O
    J Hepatol; 1999 Jul; 31(1):77-83. PubMed ID: 10424286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transection and devascularization procedures for bleeding from oesophagogastric varices.
    Idezuki Y
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):549-61. PubMed ID: 1421600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery and sclerotherapy for treatment of portal hypertension and oesophageal varices.
    Burroughs AK
    Drugs; 1989; 37 Suppl 2():25-9; discussion 47. PubMed ID: 2680429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taking the tension out of the portal system. An approach to the management of portal hypertension in the 1990s.
    Mac Mathuna P; Westaby D; Williams R
    Scand J Gastroenterol Suppl; 1990; 175():131-45. PubMed ID: 1978404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of portal hypertension.
    Samonakis DN; Triantos CK; Thalheimer U; Patch DW; Burroughs AK
    Postgrad Med J; 2004 Nov; 80(949):634-41. PubMed ID: 15537846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.